CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-18 | Walker Neal President and CEO | Exercise or conversion | +2,925 | 879,055 | ||
| 2017-12-18 | Walker Neal President and CEO | Shares withheld for taxes | −889 | $24.12 | $21K | 878,166 |
| 2017-12-18 | Walker Neal President and CEO | Exercise or conversion · Restricted Stock Units | −2,925 | 5,850 | ||
| 2017-12-18 | Ruffo Frank Chief Financial Officer | Exercise or conversion | +1,250 | 145,727 | ||
| 2017-12-18 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −380 | $24.12 | $9K | 145,347 |
| 2017-12-18 | Ruffo Frank Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,250 | 2,500 | ||
| 2017-12-18 | Powala Christopher Chief Operating Officer | Exercise or conversion | +1,625 | 134,095 | ||
| 2017-12-18 | Powala Christopher Chief Operating Officer | Shares withheld for taxes | −494 | $24.12 | $12K | 133,601 |
| 2017-12-18 | Powala Christopher Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −1,625 | 3,250 | ||
| 2017-12-18 | Ali-Jackson Kamil Chief Legal Officer | Exercise or conversion | +1,075 | 78,986 | ||
| 2017-12-18 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −327 | $24.12 | $8K | 78,659 |
| 2017-12-18 | Ali-Jackson Kamil Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −1,075 | 2,150 | ||
| 2017-12-18 | Shanler Stuart Chief Scientific Officer | Exercise or conversion | +1,450 | 264,233 | ||
| 2017-12-18 | Shanler Stuart Chief Scientific Officer | Shares withheld for taxes | −441 | $24.12 | $11K | 263,792 |
| 2017-12-18 | Shanler Stuart Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,450 | 2,900 | ||
| 2017-12-15 | Walker Neal President and CEO | Exercise or conversion | +3,033 | 877,052 | ||
| 2017-12-15 | Walker Neal President and CEO | Shares withheld for taxes | −922 | $24.23 | $22K | 876,130 |
| 2017-12-15 | Walker Neal President and CEO | Exercise or conversion · Restricted Stock Units | −3,033 | 21,233 | ||
| 2017-12-15 | Ruffo Frank Chief Financial Officer | Exercise or conversion | +1,300 | 144,872 | ||
| 2017-12-15 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −395 | $24.23 | $10K | 144,477 |
Page 48 of 57 · 1,130 trades